Thijn Brummelkamp develops and uses genetic tools to identify and characterize genes that play important roles in human disease. Recently, Thijn's group developed a novel genetic model system based on haploid human cells to enable inactivation of most human genes.
They use this approach in a variety of different projects for example to search for cancer cell vulnerabilities or to identify host factors that are hijacked by viruses to enter human cells.
